Skip to main content
. 2020 Mar 30;48(3):0300060519889187. doi: 10.1177/0300060519889187

Figure 2.

Figure 2.

The diagnostic potential of plasma levels of long non-coding RNA (lncRNA) Cancer Susceptibility 11 (CASC11) (a) and transforming growth factor (TGF)-β1 (b) for coronary artery disease (CAD) was determined using receiver operating characteristic (ROC) curve analyses. Plasma levels of lncRNA CASC11 and TGF-β1 distinguished CAD patients from healthy controls by ROC curve analysis.